焦虑相关障碍认知行为治疗的长期结局:系统综述与荟萃分析
该系统综述与荟萃分析纳入69项随机临床试验(4118例门诊患者),评估认知行为治疗对比对照条件在焦虑相关障碍中的长期结局。治疗后及随访1至12个月,认知行为治疗在广泛性焦虑障碍、惊恐障碍、社交焦虑障碍、特定恐惧症、创伤后应激障碍和强迫症中均与更好的结局相关;随访12个月以上,广泛性焦虑障碍、社交焦虑障碍和创伤后应激障碍仍显著,惊恐障碍不显著,特定恐惧症和强迫症无法计算。
要点
- 认知行为治疗对多种焦虑相关障碍在治疗后至12个月随访内均优于对照条件。
- 随访12个月以上,广泛性焦虑障碍和社交焦虑障碍效应小到中等,创伤后应激障碍效应大。
- 随访12个月以上,惊恐障碍效应不显著,特定恐惧症和强迫症无法计算。
核心结论
- 认知行为治疗对焦虑相关障碍在治疗完成后12个月内与更好的结局相关。
- 随访12个月以上,广泛性焦虑障碍和社交焦虑障碍效应小到中等,创伤后应激障碍效应大,其他障碍不显著或不可用。
研究设计与样本
- 系统综述与荟萃分析,纳入69项随机临床试验,共4118例门诊成人患者。
- 检索PubMed、PsycINFO、Embase、Cochrane、OpenGrey(1980年至2019年1月)及近期综述。
- 纳入比较认知行为治疗与对照条件(常规照护、放松、心理教育、安慰剂、支持治疗或等待名单)的随机临床试验。
- 采用随机效应模型合并数据,计算Hedges g。
主要发现
- 治疗后及随访1至6个月、6至12个月,认知行为治疗对比对照条件在广泛性焦虑障碍(Hedges g,0.07-0.40)、惊恐障碍伴或不伴广场恐惧症(Hedges g,0.22-0.35)、社交焦虑障碍(Hedges g,0.34-0.60)、特定恐惧症(Hedges g,0.49-0.72)、创伤后应激障碍(Hedges g,0.59-0.72)和强迫症(Hedges g,0.70-0.85)中与更好结局相关。
- 随访12个月以上,广泛性焦虑障碍(Hedges g,0.22;研究数k=10)、社交焦虑障碍(Hedges g,0.42;k=3)和创伤后应激障碍(Hedges g,0.84;k=5)的关联仍显著。
- 随访12个月以上,惊恐障碍伴或不伴广场恐惧症(k=5)不显著,特定恐惧症(k=1)和强迫症(k=0)无法计算。
- 3至12个月复发率为0%至14%,但仅6项随机临床试验报告(主要针对惊恐障碍伴或不伴广场恐惧症)。
关键数值与推荐
- 主要结局为治疗后及随访1至6个月、6至12个月、12个月以上焦虑症状的Hedges g。
- 随访12个月以上显著关联:广泛性焦虑障碍Hedges g=0.22(k=10),社交焦虑障碍Hedges g=0.42(k=3),创伤后应激障碍Hedges g=0.84(k=5)。
- 3至12个月复发率0%至14%,仅6项随机临床试验报告。
临床怎么用
- 认知行为治疗可作为焦虑相关障碍的有效干预,疗效至少维持至治疗后12个月。
- 对广泛性焦虑障碍、社交焦虑障碍和创伤后应激障碍,认知行为治疗的长期疗效有证据支持。
- 对惊恐障碍、特定恐惧症和强迫症的12个月以上长期疗效证据不足或不显著,需个体化评估。
局限性
- 纳入的随机临床试验主要为低质量。
- 随访12个月以上的研究数量有限,特定恐惧症和强迫症无法计算效应量。
- 复发率仅从6项随机临床试验中报告,且主要针对惊恐障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Cognitive behavioral therapy is recommended for anxiety-related disorders, but evidence for its long-term outcome is limited. OBJECTIVE: This systematic review and meta-analysis aimed to assess the long-term outcomes after cognitive behavioral therapy (compared with care as usual, relaxation, psychoeducation, pill placebo, supportive therapy, or waiting list) for anxiety disorders, posttraumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD). DATA SOURCES: English-language publications were identified from PubMed, PsycINFO, Embase, Cochrane, OpenGrey (1980 to January 2019), and recent reviews. The search strategy included a combination of terms associated with anxiety disorders (eg, panic or phobi*) and study design (eg, clinical trial or randomized controlled trial). STUDY SELECTION: Randomized clinical trials on posttreatment and at least 1-month follow-up effects of cognitive behavioral therapy compared with control conditions among adults with generalized anxiety disorder, panic disorder with or without agoraphobia, social anxiety disorder, specific phobia, PTSD, or OCD. DATA EXTRACTION AND SYNTHESIS: Researchers independently screened records, extracted statistics, and assessed study quality. Data were pooled using a random-effects model. MAIN OUTCOMES AND MEASURES: Hedges g was calculated for anxiety symptoms immediately after treatment and at 1 to 6 months, 6 to 12 months, and 12 months or more after treatment completion. RESULTS: Of 69 randomized clinical trials (4118 outpatients) that were mainly of low quality, cognitive behavioral therapy compared with control conditions was associated with improved outcomes after treatment completion and at 1 to 6 months and at 6 to 12 months of follow-up for a generalized anxiety disorder (Hedges g, 0.07-0.40), panic disorder with or without agoraphobia (Hedges g, 0.22-0.35), social anxiety disorder (Hedges g, 0.34-0.60), specific phobia (Hedges g, 0.49-0.72), PTSD (Hedges g, 0.59-0.72), and OCD (Hedges g, 0.70-0.85). At a follow-up of 12 months or more, these associations were still significant for generalized anxiety disorder (Hedges g, 0.22; number of studies [k] = 10), social anxiety disorder (Hedges g, 0.42; k = 3), and PTSD (Hedges g, 0.84; k = 5), but not for panic disorder with or without agoraphobia (k = 5) and could not be calculated for specific phobia (k = 1) and OCD (k = 0). Relapse rates after 3 to 12 months were 0% to 14% but were reported in only 6 randomized clinical trials (predominantly for panic disorder with or without agoraphobia). CONCLUSIONS AND RELEVANCE: The findings of this meta-analysis suggest that cognitive behavioral therapy for anxiety-related disorders is associated with improved outcomes compared with control conditions until 12 months after treatment completion. At a follow-up of 12 months or more, effects were small to medium for generalized anxiety disorder and social anxiety disorder, large for PTSD, and not significant or not available for other disorders. High-quality randomized clinical trials with 12 months or more of follow-up and reported relapse rates are needed.
引用
- van Dis EAM, van Veen SC, Hagenaars MA, et al. Long-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2020. PMID: 31758858. doi:10.1001/jamapsychiatry.2019.3986
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。